Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice

Robyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, Usha Chakravarthy, Varun Chaudhary, Robert P. Finger, Roberto Gallego-Pinazo, Adrian Koh Hock Chuan, Susumu Ishida, Monica Lövestam-Adrian, Mariacristina Parravano, Jose D. Luna Pinto, Steffen Schmitz-Valckenberg, Veeral Sheth, Eric H. Souied, Gloria C. Chi, Frank Gilberg, Carl Glittenberg, Stefan Scheidl, Monica Bengus

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science